Investors

Date	Name	Title	Type	Shares Traded	Price Range
Nov 27, 2012	roberts william	Officer	Acquisition (Non Open Market)	11,500	n/a
Nov 27, 2012	roberts william	Officer	Disposition (Non Open Market)	11,500	n/a
Aug 24, 2012	roberts william	Officer	Automatic Sell	3,500	n/a
Aug 22, 2008	roberts william	Officer	Acquisition (Non Open Market)	24,102	n/a
Aug 22, 2008	roberts william	Officer	Disposition (Non Open Market)	24,102	n/a
Aug 28, 2008	roberts william	Officer	Acquisition (Non Open Market)	8,106	n/a
Dec 12, 2008	roberts william	Officer	Disposition (Non Open Market)	2,400	n/a
Dec 12, 2008	roberts william	Officer	Acquisition (Non Open Market)	2,400	n/a
Nov 20, 2007	roberts william	Officer	Acquisition (Non Open Market)	34,684	n/a
Jul 15, 2010	roberts william	Officer	Acquisition (Non Open Market)	8,041	n/a
May 10, 2012	ryan arthur f	Director	Disposition (Non Open Market)	7,000	n/a
May 23, 2013	ryan arthur f	Director	Disposition (Non Open Market)	3,000	n/a
Dec 20, 2007	sanofi	Beneficial Owner (10% or more)	Statement of Ownership	0	n/a
Oct 25, 2012	schleifer leonard s	Officer	Disposition (Non Open Market)	75,938	n/a
Dec 24, 2012	schleifer leonard s	Officer	Disposition (Non Open Market)	59,271	n/a
Sep 6, 2011	schleifer leonard s	Officer	Automatic Buy	7,000	n/a
Feb 23, 2012	shooter eric m	Director	Acquisition (Non Open Market)	20,000	n/a
Feb 26, 2013	shooter eric m	Director	Acquisition (Non Open Market)	10,000	n/a
May 6, 2013	shooter eric m	Director	Acquisition (Non Open Market)	10,000	n/a
Dec 17, 2012	sing george l	Director	Disposition (Non Open Market)	10,000	n/a
Showing 41-60 of 639 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.